Loading…

Evonik has invested EUR25 million to expand and upgrade its Wesseling, Germany plant, which makes methylmercapto-propionaldehyde (MMP), a precursor for DL-methionine. The investment secures MMP supply to the Antwerp methionine hub.
Securing intermediate supply supports Evonik's European methionine output and cost position. The effect on methionine prices is small, since it mainly reduces supply risk rather than adding significant new volume.
Not enough comparable past events yet for a historical read.
Moves of each commodity's benchmark from the last close before the event. Historical reads pool past events of the same kind; they describe what happened, not what will. Not investment advice.